🇺🇸 FDA

Intelligence · Patent portfolio

Structure Therapeutics Patents

Full USPTO pharma patent portfolio for Structure Therapeutics — grant dates, expiration, and drug cross-links.

Patents
93
Expiring ≤24m
1

Quick answer

Structure Therapeutics has 93 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 2

  1. US 12279630

    Treatment and prevention of seed allergies

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12251417

    Antimicrobial compounds from the genus Delftia

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12139522

    T-cells comprising two different chimeric antigen receptors and uses thereof

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12134650

    Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer

    Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12084350

    Allotrope of carbon having increased electron delocalization

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12023348

    EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11944644

    T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11933866

    Magnetic resonance maps for analyzing brain tissue

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11932871

    Methods of culturing t cells and uses of same

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11892530

    Magnetic resonance maps for analyzing tissue

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11827687

    Synthetic somatostatin receptor ligands

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11820833

    Peptides that inhibit binding of EPCR to its ligand to treat inflammation

    Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11779565

    Small organic molecules for use in the treatment of neuroinflammatory disorders

    Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11718530

    Allotrope of carbon having increased electron delocalization

    Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11714089

    Combination of markers for diagnosing cancer

    Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11617769

    Methods of transdifferentiation and methods of use thereof

    Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11497793

    Compositions and methods for treating glioblastoma

    Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11446323

    Compositions and methods for the treatment of fibrotic diseases

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11389544

    Formation of functionalized cancer targeting nanoparticles by supramolecular co-assembly

    Expires Mon Jul 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11261230

    Synthetic somatostatin receptor ligands

    Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11219636

    Compositions and methods for treating cancer

    Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11197907

    Antimicrobial compounds from the genus Delftia

    Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11103479

    Small organic molecules for use in the treatment of neuroinflammatory disorders

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11077123

    Use of bile acids and bile salts as anti bacterial agents for inhibition of bacterial conjugation and horizontal gene transfer

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 10993948

    RNA polymerase I inhibitors and uses thereof

    Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 10947509

    Cell populations, methods of transdifferentiation and methods of use thereof

    Expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 10883994

    Identification of cancer stem cells markers and use of same for diagnosis and treatment

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 10809323

    Magnetic resonance maps for analyzing tissue

    Expires Mon Oct 15 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 10738361

    Methods of predicting clinical course and treating multiple sclerosis

    Expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 10729815

    Combined treatment for nerve injuries

    Expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 10723780

    Synthetic somatostatin receptor ligands

    Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 10668107

    Methods of transdifferentiation and methods of use thereof

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 10639350

    Methods and pharmaceutical compositions for improving wound healing using CD24

    Expires Mon Apr 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 10568901

    Micro-RNA for the treatment of malignant solid tumors and metastasis

    Expires Mon Feb 20 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 10555963

    Klotho protein and related compounds for the treatment and diagnosis of cancer

    Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 10508136

    Peptides and compositions for prevention of cell adhesion and methods of using same

    Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10465004

    Frizzled receptor antibodies for treatment of cancer

    Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10266579

    Synthetic somatostatin receptor ligands

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10265412

    Enzyme replacement therapy for treating lysosomal storage diseases

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10179151

    Methods of transdifferentiation and methods of use thereof

    Expires Mon Jan 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10113170

    Preventing and treating inflammatory skin diseases

    Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10028999

    PAR-1 based therapeutic conjugates and uses thereof

    Expires Mon Jul 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10022382

    RNA polymerase I inhibitors and uses thereof

    Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9987326

    Klotho protein and related compounds for the treatment and diagnosis of cancer

    Expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9982236

    Cell populations, methods of transdifferentiation and methods of use thereof

    Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9975944

    Synthetic peptides for the treatment of autoimmune diseases

    Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9901619

    Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes

    Expires Mon Feb 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9808488

    Isolated populations of renal stem cells and methods of isolating and using same

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Structure Therapeutics have?

93 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Structure Therapeutics patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.